Kyrgyzstan
UNDP, working in partnership with the Global Fund and national partners, has tested and put on treatment 10,500 TB patients and provided 994,000 counselling and testing encounters for HIV.
UNDP has managed Global Fund HIV and TB grants in Kyrgyzstan since 2011. The previous HIV grant focused on preventing HIV by promoting human rights, gender, good governance, and mainstreaming HIV/AIDS, whilst the TB programme supported the consolidation and expansion of Directly Observed Treatment, Short-course (DOTS), with a focus on drug resistant forms of TB.
In 2016 UNDP became PR for the joint HIV/TB programme, the overall goal of which is to reduce the HIV and TB burden by providing universal access to TB diagnosis and treatment; using evidence based HIV prevention programmes (primarily to key populations); and providing treatment care and support to people living with HIV. UNDP was principal recipient for the malaria grant between 2011 and 2015, implementing prevention measures (distribution of protective nets and treatment of houses with IRS). No local transmission of malaria occurred in Kyrgyzstan between 2011 and 2013 and in November 2016 the country received official WHO malaria-free certification.
Key results - HIV
994,000 counselling and testing encounters for HIV
Source: UNDP
3,000 people currently on antiretroviral therapy
Source: UNDP
Retention on ART 12 months after commencing treatment (2017)
Source: UNAIDS
Key results - TB
Case detection rate for TB (2017)
Source: World Health Organization
10,497 smear positive cases detected and put on treatment
Source: UNDP
Treatment success rate (2016)
Source: World Health Organization
TB incidence and mortality per 100,000 population
Source: World Health Organization
Maternal and infant mortality
Source: World Health Organization
Tackling TB in Kyrgyzstan’s prisons
Just two years ago Aziz was being carried by his cell-mates to the prison doctor, so ill he could barely stand. ust two years ago he was being carried by his cell-mates to the prison doctor, so ill he could barely stand. Although Aziz did not realize it, he was at high risk of contracting the disease having looked after a family member with TB.
I believe that it is because of the treatment that I am still alive. I also know if I stop the treatment, the disease will return and I may die like my brother did.
Thankfully for Aziz, doctors at the prison TB hospital were able to act swiftly and he began treatment immediately. The hospital is one of several supported by UNDP’s partnership with the Global Fund as part of a targeted effort to reach those at higher risk. After completing his sentence in February 2017, on just his second day after release, Aziz went to the civilian TB centre in Bishkek to ensure continuity of his treatment....
Having been referred to the prison’s specialised TB hospital, Aziz was swiftly diagnosed with multi-drug resistant TB (MDR-TB). Kyrgyzstan is among the 30 high MDR-TB burden countries in the world, creating significant challenges for the effective diagnosis and treatment of patients.
Grant details
